Tutogen purchase plan scuttled
This article was originally published in The Gray Sheet
Executive Summary
Tissue product manufacturer remains public after ending acquisition negotiations with an unspecified private equity firm. On Nov. 4, Tutogen Medical announced that the equity firm offered to buy the West Paterson, N.J. company for $94 mil. (1"The Gray Sheet" Nov. 10, 2003, In Brief). CEO Manfred Kruger cites "questions about the possibilities of this potential transaction closing by early 2004" as reason for the deal's demise...